The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Seeman, P. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,892
Kennelly, P. J., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98436-x · Cited by 1,339
Männistö, P. T., & Kaakkola, S. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01423-6 · Cited by 1,068
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., Jones, K. A., Raddatz, R., Artymyshyn, R., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 906
Amphetamine: Effects on Catecholamine Systems and Behavior
Seiden, L. S., Sabol, K. E., & Ricaurte, G. A. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.003231 · Cited by 827
Chemical structure and sympathomimetic action of amines
Barger, G., & Dale, H. H. (1910) · The Journal of Physiology · doi:10.1113/jphysiol.1910.sp001392 · Cited by 726
Shulgin, A. T., & Shulgin, A. (1991) · Cited by 668
Protein kinases that phosphorylate activated G protein‐coupled receptors
Premont, R. T., Inglese, J., & Lefkowitz, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781920 · Cited by 525
Neurotransmitter transporters as molecular targets for addictive drugs
Amara, S. G., & Sonders, M. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00068-4 · Cited by 289
Self-citation
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,209
Self-citationMammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Monoamine oxidase inactivation: from pathophysiology to therapeutics
Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone
Scanlan, T. S., Suchland, K. L., Hart, M. E., Chiellini, G., Huang, Y., Kruzich, P. J., Frascarelli, S., Crossley, D. A., Bunzow, J. R., Ronca-Testoni, S., et al. (2004) · Nature Medicine · doi:10.1038/nm1051 · Cited by 439
Self-citationMethamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder
Madras, B. K., Miller, G. M., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.011 · Cited by 393
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Berry, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02501.x · Cited by 388
Trace Amines and Their Receptors
Gainetdinov, R. R., Hoener, M. C., & Berry, M. D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015305 · Cited by 384
Tirindelli, R., Dibattista, M., Pifferi, S., & Menini, A. (2009) · Physiological Reviews · doi:10.1152/physrev.00037.2008 · Cited by 365
Revel, F. G., Moreau, J.-L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., Durkin, S., Zbinden, K. G., Norcross, R., Meyer, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103029108 · Cited by 364
Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity
Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., Bettler, B., Wettstein, J. G., Borroni, E., Moreau, J.-L., et al. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132647 · Cited by 348
Two Functional but Noncomplementing Drosophila Tyrosine Decarboxylase Genes
Cole, S. H., Carney, G. E., McClung, C. A., Willard, S. S., Taylor, B. J., & Hirsh, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414197200 · Cited by 344
A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology
Chen, H., Nwe, P.-K., Yang, Y., Rosen, C. E., Bielecka, A. A., Kuchroo, M., Cline, G. W., Kruse, A. C., Ring, A. M., Crawford, J. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.036 · Cited by 344
Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T. J., Bonab, A. A., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106583 · Cited by 326
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Halberstadt, A. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.016 · Cited by 312
“, 2009) and the trace amine receptor (Bunzow et al., 2001), and are substrates for the 5-HT transporter (SERT) (Nagai et al.”
BackgroundTrace amine-associated receptors and their ligands
Zucchi, R., Chiellini, G., Scanlan, T. S., & Grandy, D. K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706948 · Cited by 314
Self-citationThe hallucinogenic world of tryptamines: an updated review
Araújo, A. M., Carvalho, F., Bastos, M. D. L., Guedes de Pinho, P., & Carvalho, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292
Revel, F. G., Moreau, J.-L., Pouzet, B., Mory, R., Bradaia, A., Buchy, D., Metzler, V, Chaboz, S., Groebke Zbinden, K., Galley, G., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.57 · Cited by 288
A renaissance in trace amines inspired by a novel GPCR family
Lindemann, L., & Hoener, M. C. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.007 · Cited by 287
Lindemann, L., Ebeling, M., Kratochwil, N. A., Bunzow, J. R., Grandy, D. K., & Hoener, M. C. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.010 · Cited by 278
Self-citationAmphetamines, new psychoactive drugs and the monoamine transporter cycle
Sitte, H. H., & Freissmuth, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.006 · Cited by 276
Neuropharmacology of N,N-dimethyltryptamine
Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268
De Gregorio, D., Aguilar-Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 259
Miller, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07109.x · Cited by 249
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Ayahuasca: pharmacology, neuroscience and therapeutic potential
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.002 · Cited by 226
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
“Besides the serotonin 2A, 2C, and 1A receptors, DMT also displays affinity and agonist activity at the sigma-1 and trace amine associated receptors, among others (Bunzow et al., 2001; Fontanilla et al., 2009).”
BackgroundValle, M., Maqueda, A. E., Rabella, M., Rodríguez-Pujadas, A., Antonijoan, R. M., Romero, S., Alonso, J. F., Mañanas, M. À., Barker, S., Friedlander, P., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.012 · Cited by 173
The Case for TAAR1 as a Modulator of Central Nervous System Function
Rutigliano, G., Accorroni, A., & Zucchi, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00987 · Cited by 166
Pericytes impair capillary blood flow and motor function after chronic spinal cord injury
Li, Y., Lucas-Osma, A. M., Black, S., Bandet, M. V., Stephens, M. J., Vavrek, R., Sanelli, L., Fenrich, K. K., Di Narzo, A. F., Dracheva, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4331 · Cited by 164
D’Souza, D. C., Syed, S. A., Flynn, L. T., Safi-Aghdam, H., Cozzi, N. V., & Ranganathan, M. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01344-y · Cited by 162
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155
Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2
Babusyte, A., Kotthoff, M., Fiedler, J., & Krautwurst, D. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912433 · Cited by 146
Human Trace Amine-Associated Receptor TAAR5 Can Be Activated by Trimethylamine
Wallrabenstein, I., Kuklan, J., Weber, L., Zborala, S., Werner, M., Altmüller, J., Becker, C., Schmidt, A., Hatt, H., Hummel, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054950 · Cited by 122
Brito-da-Costa, A. M., Dias-da-Silva, D., Gomes, N. G. M., Dinis-Oliveira, R. J., & Madureira-Carvalho, Á. (2020) · Pharmaceuticals · doi:10.3390/ph13110334 · Cited by 117
De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.022 · Cited by 110
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Dunlap, L. E., Andrews, A. M., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00155 · Cited by 106
Blough, B. E., Landavazo, A., Decker, A. M., Partilla, J. S., Baumann, M. H., & Rothman, R. B. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3557-7 · Cited by 101
Trace Amine-Associated Receptors as Emerging Therapeutic Targets
Sotnikova, T. D., Caron, M. G., & Gainetdinov, R. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055970 · Cited by 97
“…capability that can be restored by replacing parts of the receptor sequence or the stimulatory G protein with the corresponding rat counterparts, coexpression with rat G s, promiscuous Gq, or G 16 (Bunzow et al., 2001; Lindemann and Hoener, 2005; Reese et al., 2007; Wainscott et al., 2007).”
InfluentialUnderhill, S. M., Hullihen, P. D., Chen, J., Fenollar-Ferrer, C., Rizzo, M. A., Ingram, S. L., & Amara, S. G. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0469-2 · Cited by 92
Self-citationInserra, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00330 · Cited by 91
“…receptors alpha 1A/1B/2A/2B/2C, the imidazoline 1 receptor and the trace amine associated receptor (Deliganis et al., 1991; Smith et al., 1998; Bunzow et al., 2001; Fontanilla et al., 2009; Ray, 2010). β-carbolines are obtained from Banisteriopsis caapi and function as monoamine oxidase…”
BackgroundThe blood-brain barrier and methamphetamine: open sesame?
Turowski, P., & Kenny, B.-A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00156 · Cited by 61
Wallach, J. V. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.052 · Cited by 59
Shimazu, S., & Miklya, I. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.016 · Cited by 57
In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine
Vitale, A. A., Pomilio, A. B., Cañellas, C. O., Vitale, M. G., Putz, E. M., & Ciprian-Ollivier, J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083246 · Cited by 48
Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder
Teschler, S., Bartkuhn, M., Künzel, N., Schmidt, C., Kiehl, S., Dammann, G., & Dammann, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084180 · Cited by 36
“and activates adenylyl cyclase signaling pathway [41].”
Zhukov, I. S., Karpova, I. V., Krotova, N. A., Tissen, I. Y., Demin, K. A., Shabanov, P. D., Budygin, E. A., Kalueff, A. V., & Gainetdinov, R. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214066 · Cited by 24
Rat Brain-Uptake Index for Phenylethylamine and Various Monomethylated Derivatives
Mosnaim, A. D., Callaghan, O. H., Hudzik, T., & Wolf, M. E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0988-1 · Cited by 24
“Some of the most potent known exogenous ligands for this receptor, include AMPH, methamphetamine, methylenedioxymethamphetamine, and lysergic acid diethylamide (LSD) [8], at which they appear to act as agonists in addition to each of their already welldescribed dopamine transporter inhibition and serotonergic activity…”
Metadata
- Authors
- Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., Olson, S. B., Magenis, R. E., Amara, S. G., & Grandy, D. K.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 60
- Issue
- 6
- Pages
- 1181-1188
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2343195587
- Cited by
- 648
- References
- 33
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.